Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 601-147-9 | CAS number: 111988-49-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Remarks:
- Preliminary dose range-finder included in the acute oral neurotoxicity screening study 95-412-GI (please refer to M-000894-03-1 in chapter 7.9.1)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- main study: 29 Jan - 16 Feb 1996
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Data provided as summary within an reliable acute oral neurotoxicity screening study; however considered reliable and suitable for assessment of the acute oral toxicity.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted 1987
- Deviations:
- yes
- Remarks:
- only summarized data available
- Principles of method if other than guideline:
- The present study was intended as dose range-finding study to define the most appropriate dose levels for a further acute oral neurotoxicity screening study. Accordingly, the data referring to the present study are part of the study No. 95-412-GI as available for the acute oral neurotoxicity screening study, included in IUCLID chapter 7.9.1.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 3-(2-chlor-5-pyridyl-methyl)-cyanimino-1,3-thiazolidin
- EC Number:
- 601-147-9
- Cas Number:
- 111988-49-9
- Molecular formula:
- C10H9ClN4S
- IUPAC Name:
- 3-(2-chlor-5-pyridyl-methyl)-cyanimino-1,3-thiazolidin
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: not specified, but Wistar assumed
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- No details available from the data source.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on oral exposure:
- No details on the experimental design are available from the data source, however, it is hardly assumed that these were similar to those as described from the main screening study. With respect to the screening study, the test substance was administered by gavage as a single dose in 0.5% methylcellulose-0.4% Tween 80 in deionized water, at a dosing volume of 10 mL/kg bw.
- Doses:
- 27, 36, 85, 244 and 526 mg/kg bw (analytically-confirmed doses)
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- None
- Statistics:
- Not specified
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 85 - < 244 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 0% mortality at 85 mg/kg bw and 100 % mortality at the next dose level of 244 mg/kg bw
- Mortality:
- 27, 36 and 85 mg/kg bw: no deaths occurred in both sexes
244 and 526 mg/kg bw: 100% mortality in both sexes - Clinical signs:
- other: 27 mg/kg bw: no clinical signs were observed 36 mg/kg bw: slight repetitive chewing movements (males) 85 mg/kg bw: slight repetitive chewing movements (both sexes), slight tremors (males) and slight oral and nasal stains (female) 244 mg/kg bw: tremors, de
- Gross pathology:
- No information on gross pathology was provided.
- Other findings:
- Neurotoxicity:
The time of peak neurobehavioral effects (within the first eight hours following treatment) was estimated to be approximately 4 h following treatment.
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- The present study was intended as dose range-finding study to define the most appropriate dose levels for a further acute oral neurotoxicity screening study. The data referring to the present study are part of the study No. 95-412-GI, as available for the acute oral neurotoxicity screening study included in IUCLID chapter 7.9.1. The test conduct of the range finding study was in principle similar to OECD TG 401, and analytically-confirmed doses of 27, 36, 85, 244 and 526 mg/kg bw were tested using five rats/sex/dose level. Clinical signs of toxicity were reported, starting from 36 mg/kg bw, which basically consisted of repetitive chewing movements, slight tremors and oral and nasal stains. At the two highest dose levels of 244 and 526 mg/kg bw, the toxic effects further included decreased activity, cool-to-touch body, dilated pupils and clear lacrimation. At 244 mg/kg bw, locomotor incoordination (ataxia) was reported for one female. Clinical signs were generally apparent in both sexes within 2 - 4 h following treatment and recovered in survivors by the following day. Clinical signs were generally comparable for males and females at a given dose level, indicating similar sensitivity for both sexes. With respect to neurotoxicity, it was reported that the time of peak neurobehavioral effects (within the first eight hours following treatment) could be estimated to be approximately four hours following treatment.
Whereas no mortality occurred at doses from 27 to 85 mg/kg bw, 100% mortality was observed at the two highest dose levels of 244 and 526 mg/kg bw, which generally occurred within 24 h after dosing. Thus, a LD50 for acute oral toxicity in the range > 85 - < 244 mg/kg bw is expected. Referring to the CLP classification and labelling criteria (CLP, Annex I), this falls in the range of > 50 - =< 300 mg/kg bw and thus, would trigger a classification for acute oral toxicity as Cat 3 H301.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.